Table 2

HRs (95% CI) of heart failure and pulmonary heart disease associated with 10 bpm higher resting heart rate after excluding participants with prior diseases

OutcomeEvents (n)HR* (95% CI)
Heart failure
 Main model37491.25 (1.17 to 1.34)
 Excluding prior non-vascular disease†26341.14 (1.05 to 1.24)
 Excluding poor self-rated health37271.18 (1.09 to 1.28)
 Excluding the first 5 years of follow-up27451.23 (1.14 to 1.33)
 Excluding prior stroke and those on aspirin, and BP-lowering medication29291.31 (1.21 to 1.41)
 Excluding HF cases secondary to first PHD diagnosis35111.20 (1.12 to 1.29)
Pulmonary heart disease
 Main model55721.74 (1.67 to 1.81)
 Excluding prior non-vascular disease†23971.39 (1.30 to 1.48)
 Excluding poor self-rated health38241.59 (1.51 to 1.67)
 Excluding the first 5 years of follow-up36991.59 (1.51 to 1.68)
 Excluding prior stroke and those on aspirin, and BP-lowering medication53071.79 (1.72 to 1.87)
 Excluding PHD cases secondary to first HF diagnosis53091.75 (1.68 to 1.83)
  • n=frequency. All analyses were adjusted for age-at-risk, sex, season, region, socioeconomic factors (education, household income and marital status); CVD risk factors (alcohol consumption, physical activity, smoking, systolic blood pressure, body mass index and self-reported diagnosis of diabetes mellitus and hypertension diagnosed by a medical doctor). All analyses were stratified by age-at-risk and region.

  • The risk of heart failure per 10 bpm higher usual resting heart rate was only estimated for usual RHR≥75 bpm where the shape of the association of usual resting heart rate with heart failure was approximately linear.

  • *All HRs are per 10 beats per minute higher usual heart rate.

  • †Prior non-vascular disease (chronic obstructive pulmonary disease, emphysema, bronchitis, pulmonary tuberculosis, asthma, any cancer, rheumatoid arthritis, chronic hepatitis or cirrhosis and chronic kidney disease).

  • BP, blood pressure; PHD, pulmonary heart disease.